Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) Return on Capital Employed (2018 - 2026)

Viemed Healthcare filings provide 8 years of Return on Capital Employed readings, the most recent being 14.37% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 121.0% to 14.37% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.37%, a 121.0% increase, with the full-year FY2025 number at 15.61%, up 169.0% from a year prior.
  • Return on Capital Employed hit 14.37% in Q4 2025 for Viemed Healthcare, up from 14.09% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 25.84% in Q1 2021 to a low of 8.15% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 12.19% (2024), compared with a mean of 12.63%.
  • The widest YoY moves for Return on Capital Employed: up 679bps in 2021, down -1881bps in 2021.
  • Viemed Healthcare's Return on Capital Employed stood at 11.71% in 2021, then dropped by -29bps to 8.3% in 2022, then skyrocketed by 44bps to 11.94% in 2023, then grew by 10bps to 13.16% in 2024, then increased by 9bps to 14.37% in 2025.
  • The last three reported values for Return on Capital Employed were 14.37% (Q4 2025), 14.09% (Q3 2025), and 14.59% (Q2 2025) per Business Quant data.